Acquisitions Continue to Drive Amedisys’ Hospice Growth

Acquisitions contributed significantly to the Amedisys (AMED) hospice segment growth during the fourth quarter of 2019, continuing a trend for the past several quarters. The company was active in the hospice M&A space last year, completing several transactions that included its $340 million purchase of Compassionate Care Hospice in February and its tuck-in of RoseRock Healthcare for an undisclosed amount. The company will seek additional acquisitions throughout the year. “We continue to be very interested in hospice tuck-ins and we’ll look to do more this year. We are most excited though about 2021 and 2022 …” Amedisys CEO Paul Kusserow said in an earnings conference call. “Our new hospice assets will be fully integrated and operating at our legacy growth rate and margin levels.”

Read the full article: Acquisitions Continue to Drive Amedisys’ Hospice Growth //


Scroll to Top